Is antidyslipidemic statin use for cancer prevention a promising drug repositioning approach?
Kobayashi Y, Banno K, Kunitomi H, Nagai S, Takahashi T, Anko M, Iijima M, Takeda T, Matoba Y, Nakamura K, Tsuji K, Tominaga E, Aoki D.
Kobayashi Y, et al.
Eur J Cancer Prev. 2019 Nov;28(6):562-567. doi: 10.1097/CEJ.0000000000000497.
Eur J Cancer Prev. 2019.
PMID: 30418231
Review.